Turning Point Therapeutic...

NASDAQ: TPTX · Real-Time Price · USD
75.49
0.09 (0.12%)
At close: Aug 15, 2022, 10:00 PM

Turning Point Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
290.15M 309.53M 427.88M 404.2M 426.05M 469.17M
Short-Term Investments
528.14M 608.65M 553.7M 631.81M 651.76M 645.61M
Long-Term Investments
n/a n/a n/a n/a n/a n/a
Other Long-Term Assets
2.04M 2.04M 2.02M 2.02M 2.02M 107K
Receivables
n/a n/a n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a n/a n/a
Other Current Assets
13.38M 9.24M 10.88M 11.13M 13.61M 7.13M
Total Current Assets
831.67M 927.43M 992.46M 1.05B 1.09B 1.12B
Property-Plant & Equipment
9.63M 9.31M 8.98M 9.82M 9.48M 5.57M
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
11.67M 11.36M 11M 11.84M 11.5M 5.67M
Total Assets
843.34M 938.79M 1B 1.06B 1.1B 1.13B
Account Payables
7.93M 7.61M 5.66M 3.19M 7.09M 6.78M
Deferred Revenue
n/a n/a n/a n/a n/a n/a
Short-Term Debt
4.05M 3.96M 3.63M 3.5M 2.98M 1.44M
Other Current Liabilities
37.44M 33.99M 37.8M 32.07M 21.82M 16.15M
Total Current Liabilities
49.42M 45.57M 47.09M 38.75M 31.89M 24.37M
Long-Term Debt
890K 1.87M 1.95M 2.9M 3.52M 2.05M
Other Long-Term Liabilities
n/a n/a n/a n/a n/a n/a
Total Long-Term Liabilities
890K 1.87M 1.95M 2.9M 3.52M 2.05M
Total Liabilities
50.31M 47.44M 49.04M 41.65M 35.41M 26.42M
Total Debt
4.94M 5.83M 5.58M 6.39M 6.5M 3.49M
Common Stock
5K 5K 5K 5K 5K 5K
Retained Earnings
-714.26M -591.17M -516.73M -438.28M -371.95M -315.68M
Comprehensive Income
-6.91M -5.39M -1.27M -16K 2K 23K
Shareholders Equity
793.02M 891.35M 954.42M 1.02B 1.07B 1.1B
Total Investments
528.14M 608.65M 553.7M 631.81M 651.76M 645.61M